CRP Cancer Research Results

CRP, C-reactive protein: Click to Expand ⟱
Source:
Type:
C-Reactive Protein (CRP) is a protein produced by the liver in response to inflammation in the body.
C-reactive protein is an acute-phase reactant synthesized by the liver in response to IL-6–driven inflammation.

In oncology, it serves as a host-response biomarker, not a tumor marker.

An elevated CRP integrates multiple cancer-relevant processes:
-Tumor-associated inflammation and necrosis
-Cytokine signaling (especially IL-6)
-Infection or treatment-related tissue injury
-Cachexia and systemic catabolism

Because it aggregates these signals, CRP is a powerful global severity indicator.

Prognosis (Primary Use)
-Higher baseline CRP correlates with shorter overall survival across many cancers.
-Rising CRP often precedes clinical decline.

Treatment Tolerance & Risk
-Elevated CRP predicts poor chemotherapy tolerance, higher complication rates, and inferior immunotherapy outcomes in several settings.


Nor, Normal Healthy: Click to Expand ⟱
Normal Healthy

Scientific Papers found: Click to Expand⟱
5926- CAR,    An Updated Review of Research into Carvacrol and Its Biological Activities
- Review, Nor, NA - Review, AD, NA - Review, asthmatic, NA
*Inflam↓, *antiOx↑, *neuroP↑, *BioAv↑, *toxicity↓, *Pain↓, *TRPV3↑, *NRF2↑, *Ca+2↑, *ATP↑, *5LO↓, *COX2↓, PGE2↓, *hepatoP↑, *AntiAg↑, *Diar↓, *cardioP↑, *other↝, *chemoPv↑, *cognitive↑, *AChE↓, *GastroP↑, *eff↑, *BChE↓, *CRP↓,
4601- SeNPs,  AgNPs,    Antioxidant and hepatoprotective role of selenium against silver nanoparticles
- in-vivo, Nor, NA
*TAC↑, *CRP↓, *AST↓, *ALAT↓, *toxicity↓, *GSH↑, *SOD↑, *Catalase↑, *hepatoP↑,
3409- TQ,    Thymoquinone therapy remediates elevated brain tissue inflammatory mediators induced by chronic administration of food preservatives
- in-vivo, Nor, NA
*MDA↓, *TGF-β↓, *CRP↓, *NF-kB↓, *TNF-α↓, *IL1β↓, *Casp3↓, *GSH↑, *NRF2↑, *IL10↑, *neuroP↑, *ROS↓, *Apoptosis↓, *Inflam↓,
3111- VitC,    https://pmc.ncbi.nlm.nih.gov/articles/PMC4492638/
- Trial, Nor, NA
Inflam↓, CRP↓, IL6↓,
3112- VitC,    Antioxidative and Anti-Inflammatory Activity of Ascorbic Acid
- Review, Nor, NA
*ROS↓, *antiOx↑, *SOD↑, *Catalase↑, *GPx↑, *NRF2↑, *AP-1↑, *Inflam↓, *CRP↓, IFN-γ↓,

Showing Research Papers: 1 to 5 of 5

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5

Pathway results for Effect on Cancer / Diseased Cells:


Immune & Inflammatory Signaling

CRP↓, 1,   IFN-γ↓, 1,   IL6↓, 1,   Inflam↓, 1,   PGE2↓, 1,  

Clinical Biomarkers

CRP↓, 1,   IL6↓, 1,  
Total Targets: 7

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 2,   Catalase↑, 2,   GPx↑, 1,   GSH↑, 2,   MDA↓, 1,   NRF2↑, 3,   ROS↓, 2,   SOD↑, 2,   TAC↑, 1,  

Mitochondria & Bioenergetics

ATP↑, 1,  

Core Metabolism/Glycolysis

ALAT↓, 1,  

Cell Death

Apoptosis↓, 1,   Casp3↓, 1,  

Kinase & Signal Transduction

TRPV3↑, 1,  

Transcription & Epigenetics

other↝, 1,  

Migration

5LO↓, 1,   AntiAg↑, 1,   AP-1↑, 1,   Ca+2↑, 1,   TGF-β↓, 1,  

Barriers & Transport

GastroP↑, 1,  

Immune & Inflammatory Signaling

COX2↓, 1,   CRP↓, 4,   IL10↑, 1,   IL1β↓, 1,   Inflam↓, 3,   NF-kB↓, 1,   TNF-α↓, 1,  

Synaptic & Neurotransmission

AChE↓, 1,   BChE↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 1,   eff↑, 1,  

Clinical Biomarkers

ALAT↓, 1,   AST↓, 1,   CRP↓, 4,  

Functional Outcomes

cardioP↑, 1,   chemoPv↑, 1,   cognitive↑, 1,   hepatoP↑, 2,   neuroP↑, 2,   Pain↓, 1,   toxicity↓, 2,  

Infection & Microbiome

Diar↓, 1,  
Total Targets: 43

Scientific Paper Hit Count for: CRP, C-reactive protein
2 Vitamin C (Ascorbic Acid)
1 Carvacrol
1 Selenium NanoParticles
1 Silver-NanoParticles
1 Thymoquinone
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:49  Cells:%  prod#:%  Target#:884  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page